Bangladesh

in page functions
[French]
Bangladesh
Total population (2018) 166,724,957
Birth cohort (2018) 3,073,697
Surviving Infants (surviving to 1 year per year, 2018) 2,997,362
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 38/1000
World Bank Index, IDA (2015) 3.31
Gross Nation Income (per capita US$, 2015) 1,190
No. of districts/territories (2017) 64

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Bangladesh

Type of support

Approvals

2001-2023 (US$)
(2 Jul 2019)

Commitments

2001-2023 (US$)
(2 Jul 2019)

Disbursements

2000-2019 (US$)
(2 Jul 2019)

% Disbursed

(2 Jul 2019)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Total $738,348,946 $837,287,860 $673,809,472
Cash Support (CASHSUPP) $333,500 $358,500 $333,500 100%
Health system strengthening (HSS 1) $13,671,500 $13,671,500 $13,671,500 100%
Health system strengthening (HSS 2) $37,922,731 $37,922,731 $33,738,731 89%
Health system strengthening (HSS 3) $30,815,516 $53,422,930
HepB mono (NVS) $20,224,465 $20,224,465 $20,224,465 100%
HPV Demo (NVS) $715,990 $715,990 $716,562 100%
Immunisation services support (ISS) $23,340,200 $23,340,200 $23,340,200 100%
Injection Safety Devices (NVS) $5,739,460 $7,484,960 $2,014,410 35%
Injection safety support (INS) $6,144,414 $6,144,414 $6,144,414 100%
IPV (NVS) $20,930,409 $20,930,409 $15,865,832 76%
IPV Catch-up RI (NVS) $1,748,500 $1,748,500 $1,021,508 58%
Measles (NVS) $9,702,862 $9,702,862 $9,740,021 100%
Measles-Rubella (NVS) $36,040,812 $36,040,812 $36,046,414 100%
MR - Operational costs (OPC) $33,586,500 $33,586,500 $33,586,500 100%
MR 1st and 2nd dose (NVS) $494,500 $494,500 $506,385 102%
MR-Catch-up campaign (NVS) $189,500 $189,500 $195,399 103%
MR-Follow-up campaign (NVS) $10,749,000 $10,749,000
MR-Follow-up campaign op.costs (OPC) $8,611,116 $8,611,116
Operational costs (OPC) $451,257 $451,257 $451,257 100%
Penta (NVS) $253,069,087 $273,640,087 $261,337,446 103%
Penta - campaign (NVS) $146,500 $146,500
Pneumo (NVS) $212,430,912 $266,420,912 $206,281,213 97%
Product Switch Grant (PSG) $279,715 $279,715 $279,715 100%
Rotavirus (NVS) N/A
Vaccine Introduction Grant (VIG) $11,010,500 $11,010,500 $8,314,000 76%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Bangladesh DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2013) 90.40%
Household survey: DTP3 coverage for female (2013) 92.30%
Household survey: Last DTP3 survey (2013) 91%
% districts achieving > 80% DTP3 coverage (2017) 100%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 94%

Breakdown of support

Non-vaccine support Vaccine support
18% 82%
$119,859,817 $553,949,655

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Bangladesh

31 May 2019

Women Deliver - HPV Ghana 2013

Immunisation as a catalyst for women's health, education, and economic empowerment

Women Deliver 2019 will be the world’s largest conference on gender equality and the health, rights, and wellbeing of girls and women. As a gender equal health intervention, immunisation plays a key role in keeping girls, adolescents and women healthy.

10 December 2018

Gavi item

South Korea pledges US$15 million to immunise children in world's poorest countries

New funding will help Gavi, the Vaccine Alliance, vaccinate millions of children against deadly diseases.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here